Atsutaka Yasui

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Journal of diabetes investigation

Nature reviews. Nephrology

Diabetes, obesity & metabolism

Expert opinion on drug safety

Nippon Boehringer Ingelheim Co., Ltd.

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Nippon Boehringer Ingelheim Co., Ltd. Dec 01 2016

Japan

Head of Empagliflozin Medical Affairs in Japan :: Medicine

Takeda Pharmaceutical Company Apr 01 2008 - Nov 30 2016

Japan

Principal Scientist

Publications

Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation 14 (3) (2023)
Dae-Jung Kim, Wayne Huey Herng Sheu, Wook-Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia-Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz-Luyet, Moe H Kyaw, Yutaka Seino, null null
Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study. Journal of diabetes investigation (2023)
Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Hristo Lliev, Atsutaka Yasui
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study. Expert opinion on drug safety 21 (10) (2022)
Kohei Kaku, Christoph Wanner, Stefan D Anker, Stuart Pocock, Atsutaka Yasui, Michaela Mattheus, Søren S Lund
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease. Diabetes, obesity & metabolism 24 (4) (2022)
Adriana Marton, Tatsuroh Kaneko, Jean-Paul Kovalik, Atsutaka Yasui, Akira Nishiyama, Kento Kitada, Jens M Titze
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation. Nature reviews. Nephrology 17 (1) (2020)
Yutaka Seino, Dae-Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei-Yu Lei, Sunwoo Lee, Moe H Kyaw, Anouk Déruaz-Luyet, Kimberly G Brodovicz, Wayne Huey Herng Sheu, null null
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study. Endocrinology, diabetes & metabolism 4 (1) (2020)

Atsutaka Yasui.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Atsutaka Yasui